FDA inspection

Merck Serono SA: FDA inspection ending Nov 25, 2025

FDA inspection 1298388 · No Action Indicated (NAI) · Aubonne

Key facts

Inspection ID 1298388
Firm Merck Serono SA
FEI number 3002807447
Address Zone Industrielle, De L'Ouriettaz
City Aubonne
Fiscal year 2026
Inspection end date Nov 25, 2025
Classification No Action Indicated (NAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections